Advancing

CRISPR

Technology

Advancing

CRISPR

Technology

Scroll for more

Innovative solutions using next generation CRISPR-Cas12a technology

Gene editing

Operating at the forefront of gene editing.

Our structure-based rational design that stems from structural insights* on CRISPR-Cas12a system allows us to manipulate and optimize its activity for therapeutic purposes.

*The foundational structural analysis of the CRISPR-Cas12a system was performed in the Montoya Research Group within the Protein Structure & Function Program at the University of Copenhagen, Novo Nordisk Foundation Center for Protein Research. (Stella et al., 2017 Nature, Stella et al., 2018 Cell).

Supported by

Contact us

To learn about our technology and the opportunities it brings within gene editing.

Hello@twelve.bio
+45 31 33 35 44

GET IN TOUCH

hello@twelvebio.com / +45 31 33 35 44 / @BII Ole Maal√łes Vej 3 / 2200 Copenhagen / Denmark

Cookies